Skip to main content
Livermore
Livermore
ZHEN

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
509,302
Value
$46.2M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026509,302$46.2M0.1%+57,550+12.7%AddedHolders
Q1 2026451,752$46.4M0.1%−7,923−1.7%ReducedHolders
Q4 2025459,675$57.6M0.1%−7,046−1.5%ReducedHolders
Q3 2025466,721$62.5M0.1%+6,296+1.4%AddedHolders
Q2 2025460,425$62.6M0.1%+12,105+2.7%AddedHolders
Q1 2025448,320$59.5M0.1%+62,400+16.2%AddedHolders
Q4 2024385,920$43.7M0.1%+8,363+2.2%AddedHolders
Q3 2024377,557$43.0M0.1%−69,739−15.6%ReducedHolders
Q2 2024447,296$46.5M0.1%−7,038−1.5%ReducedHolders
Q1 2024454,334$51.6M0.2%+12,847+2.9%AddedHolders
Q4 2023441,487$48.6M0.2%+62,168+16.4%AddedHolders
Q3 2023379,319$36.7M0.1%+16,470+4.5%AddedHolders
Q2 2023362,849$39.6M0.2%+12,220+3.5%AddedHolders
Q1 2023350,629$35.5M0.2%+9,585+2.8%AddedHolders
Q4 2022341,044$37.4M0.2%+4,724+1.4%AddedHolders
Q3 2022336,320$32.5M0.2%+12,742+3.9%AddedHolders
Q2 2022323,578$35.2M0.2%+32,639+11.2%AddedHolders
Q1 2022290,939$34.4M0.2%+13,129+4.7%AddedHolders
Q4 2021277,810$39.1M0.3%+2,247+0.8%AddedHolders
Q3 2021275,563$32.6M0.3%+29,240+11.9%AddedHolders
Q2 2021246,323$28.6M0.3%+18,184+8.0%AddedHolders
Q1 2021228,139$27.3M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.